Eligible academic labs at US universities can receive up to 30 Business Standard seats at $0 per user per month for up to 12 months under the Rosalind Academic Plan, with GPT-Rosalind access subject to trusted-access approval.

● OPEN · settles 2026-10-19

Background

OpenAI is giving its life sciences model away to universities, with a gatekeeper. Under the Rosalind Academic Plan, eligible labs at US universities can receive up to 30 Business Standard seats at no cost for up to 12 months, including access to GPT-Rosalind, its specialized model for medicinal chemistry, genomics, drug and protein design and wet-lab assistance, once they clear trusted-access approval. Labs whose universities already hold an OpenAI Enterprise agreement apply through that channel instead. API access is not included, and research data shared through the plan is not used to train models by default. The vetting is the other half of the announcement: OpenAI verifies the institution and the lab lead, reviews their background, appointment and intended use, and requires a designated institutional safety contact, with monitoring and enforcement continuing after activation. Labs already working with the model are applying it to protein design and neurodegeneration research. The bargain is plain: wider access to a frontier biology model for academic science, wrapped in the access controls OpenAI applies to its most sensitive capabilities.

This market exists because launch announcements are easy to make and hard to grade. Press releases describe what a company intends to ship; they rarely come back later to say whether it shipped. AI Rank Bank pulls one checkable sentence out of the coverage — the sentence above — gives it a date, and lets readers price it in public. The launch itself stays with its publisher; what lives here is the claim, the crowd's call, and eventually the receipt.

How this claim is judged

Judging criteria, fixed when the market opened: Delivered if, at the check time, OpenAI's plan and help center pages still offer eligible US academic labs up to 30 Business Standard seats at $0 per user per month for up to 12 months, with GPT-Rosalind available after trusted-access approval. The plan having been withdrawn, priced, or cut materially below 30 seats or 12 months does not count.

The source of record is the publisher's own page linked above. A claim about a company's product is judged against that company's public output — its product pages, documentation, changelogs and official posts — not against rumors or third-party summaries. Only yes-or-no outcomes count: partial credit is not a verdict, and a claim that needs a paragraph of excuses has already answered itself.

How readers called it

No calls yet — the bar is empty and the claim is unpriced.

No reader calls yet. The first call on a claim is priced against a neutral crowd, and pays 50 points if it lands.

Points reward being right against the crowd. A correct call pays 100 × (1 − the share of readers who agreed with you when you placed it), with a floor of 10: side with a 90% consensus and a win pays 10, stand alone and a win pays up to 100. Wrong calls pay nothing. The price is locked in when the call is placed, so early readers are paid for judging before the crowd forms, not for copying it.

How readers split

The split line starts with this market's first snapshots — a point is recorded whenever a reader calls the claim, and at least once an hour while it stays open. Check back after the crowd has moved and the line will be here.

Verdict

No verdict yet. This claim is checked on 2026-10-19 08:00 Eastern Time (12:00 UTC) against the source of record below. When the check happens, one of three stamps lands on this page permanently: delivered if the claim came true as stated, busted if it did not, or unproven if the date passes without public evidence either way. Unproven claims pay no points and do not count against any reader's hit rate.

About this market

AI Rank Bank is an AI news front page with a memory. Every launch on the homepage carries one claim like this one, with a check date. Readers call claims with points, build a public record, and climb the leaderboard. Companies build a record too: every settled claim lands on the company's bank page, where its delivery rate is simple arithmetic that nobody gets to edit afterwards. There is no money in the market — points buy bragging rights only, which keeps the incentives pointed at being right.